No takes yet. Share an insight, caveat, or question.
Translational study demonstrates reduced relapse, graft rejection, and GVHD from donor NK-cell alloreactivity in hematopoietic transplants, indicating a safer graft approach.
Ruggeri et al. (2002) studied this question.